Surmodics Acquires Vetex Medical Limited

GTCR to Acquire Surmodics for $43.00 per Share; Equity Value Approximately $627M

May 29, 2024

Medical Devices

GTCR, a leading private equity firm, will acquire Surmodics, a Minnesota-based medical device and in vitro diagnostic technologies company, for $43.00 per share in cash, implying an approximate equity value of $627 million. The transaction, unanimously approved by Surmodics' board, is expected to close in the second half of 2024 and will take Surmodics private following customary regulatory and shareholder approvals.

Haemonetics Acquires Vivasure Medical

January 11, 2026

Medical Devices

Haemonetics Corporation has acquired Galway-based Vivasure Medical in a transaction valued at up to €185 million, consisting of an upfront €100 million payment plus up to €85 million in contingent milestone payments. The acquisition adds Vivasure's PerQseal Elite fully bioabsorbable vascular closure system to Haemonetics' large-bore closure portfolio; Vivasure has CE Mark approvals and has submitted a PMA to the U.S. FDA.

Surmodics Merges with Biocoat; Forms Surmodics Services & Technologies Division

December 10, 2025

Medical Devices

Surmodics has completed a merger with Biocoat and formed a new division, Surmodics Services & Technologies (SST), to carry forward the portion of Biocoat's business remaining after divesting certain assets. SST, based in Horsham, Pennsylvania, will provide hydrophilic coating technologies, custom polymer formulations and full-service coating operations to medical device manufacturers worldwide.

Boston Scientific Acquires Devoro Medical

September 21, 2021

Medical Devices

Boston Scientific agreed to acquire the remaining 84% of Devoro Medical, developer of the WOLF Thrombectomy Platform, paying approximately $269 million upfront plus up to $67 million in milestone payments. Boston Scientific had been a strategic investor in Devoro since 2019 (holding ~16%); the acquisition expands Boston Scientific’s clot-management and peripheral interventions product portfolio by adding a non-console, lytic-free thrombectomy technology.

Veranex Acquires Medidee to Expand European MedTech Capabilities

September 20, 2022

Healthcare Services

Veranex has acquired Medidee, a Lausanne-based MedTech regulatory and clinical consultancy, expanding Veranex's footprint and capabilities across Europe, India and APAC. The deal strengthens Veranex’s regulatory affairs, clinical development, and quality assurance services for medical device and in vitro diagnostic clients; financial terms were not disclosed.

Arterex (Investindustrial-backed) Acquires NextPhase Medical Devices

July 17, 2023

Medical Devices

Arterex (Medical Device, Inc.), an Investindustrial-backed medical device contract manufacturer, has acquired NextPhase Medical Devices from Kidd & Company, LLC. The deal expands Arterex’s global multi-capability platform — nearly doubling the group’s scale and adding complementary design, engineering and complex electromechanical and implantable device manufacturing capabilities across North America and internationally.